Results 211 to 220 of about 259,030 (331)

Straight to Phase III: Model‐Informed Approach Speeds Depemokimab Clinical Development in Interleukin‐5‐Driven Diseases

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Straight to Phase III: Model‐informed approach speeds depemokimab clinical development in interleukin‐5‐driven diseases. IL‐5, a key mediator of type 2 inflammation, underlies various diseases, including severe asthma, CRSwNP, EGPA, and HES. Reduction in blood eosinophil count (BEC), a biomarker of IL‐5 activity, is commonly used to evaluate the ...
Chiara Zecchin   +6 more
wiley   +1 more source

Editorial [PDF]

open access: yes, 2019
Iosifidis, P.
core   +1 more source

Social Media Green Marketing: How Self‐Monitoring Shapes Consumer Engagement and Eco‐Purchase Intentions

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Marketing scholars and practitioners are paying increasing attention to social media as a crucial tool for communicating firms' sustainable activities to consumers. This study examines how consumers perceive and engage with social media green marketing, and how their engagement influences their intentions to purchase green products and brands,
So‐Young Jung, Su‐Yol Lee
wiley   +1 more source

Purpose and Profit: Social and Environmental Marketing for Large Companies in Adverse Scenarios

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This qualitative study explored how large companies use social and environmental marketing to boost results in adverse scenarios, analyzing interviews with marketing managers and public documents. The findings reveal distinct strategies. To attract investors, environmental, social, and governance (ESG) communication is targeted at limited ...
Celso Jacubavicius   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy